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Abstract
Diagnosing bacterial infection (BI) remains a challenge for the attending physician. An ex vivo infection model based on
human fixed polymorphonuclear neutrophils (PMNs) gives an autofluorescence signal that differs significantly between
stimulated and unstimulated cells. We took advantage of this property for use in an in vivo pneumonia mouse model and in
patients hospitalized with bacterial pneumonia. A 2-fold decrease was observed in autofluorescence intensity for
cytospined PMNs from broncho-alveolar lavage (BAL) in the pneumonia mouse model and a 2.7-fold decrease was observed
in patients with pneumonia when compared with control mice or patients without pneumonia, respectively. This optical
method provided an autofluorescence mean intensity cut-off, allowing for easy diagnosis of BI. Originally set up on a
confocal microscope, the assay was also effective using a standard epifluorescence microscope. Assessing the
autofluorescence of PMNs provides a fast, simple, cheap and reliable method optimizing the efficiency and the time
needed for early diagnosis of severe infections. Rationalized therapeutic decisions supported by the results from this
method can improve the outcome of patients suspected of having an infection.
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Introduction
Severe bacterial infection (BI) remains a major cause of hospital
morbidity and mortality, specifically in intensive care units (ICU).
The correlation between mortality and the delay in starting
antibiotics has been clearly demonstrated in current literature [1–
3]. The challenge is therefore to promptly diagnose BI to provide
rapid antibiotic treatment in order to improve survival rates.
Another challenge is to reduce the daily overuse of antibiotics in
order to reduce both antimicrobial resistance and costs. In this
context, the duration of antibiotic treatment has been the subjects
of heated debates. The development of rapid techniques for not
only diagnosing, but also for monitoring an ongoing infection
during antibacterial treatment, is required. These techniques will
enable the discontinuation of treatment when appropriate,
resulting shorter duration of antibiotic use and a reduction in
their overall consumption.
Diagnosis of BI is currently performed by direct Gram staining
and bacterial culture. While Gram staining is a rapid procedure
[4], its efficacy for diagnosing infection remains poor. Bacterial
culture may require at least one day to obtain a bacteriological
diagnosis. Recently, new approaches, such as reverse transcriptase-
polymerase chain reaction assays [5] or procalcitonin (PCT) [6]
dosing have been developed, but these diagnostic tools have not
been fully validated to diagnose infections early and accurately and
are expensive owing to the sophisticated equipment required. In
order to complement these microbiological or biomarker ap-
proaches, there is an urgent need to develop rapid, reliable, and
cheap methods, easily applied in hospitals and biomedical
laboratories, in order to enhance early infection diagnosis and to
monitor infection progress faster than what is currently available.
We therefore investigated BI diagnosis by autofluorescence
emission of the host’s polymorphonuclear neutrophils (PMNs), the
first cells recruited from the site of infections. These cells play a
crucial role in a pathogen’s recognition and destruction. Stimu-
lation of PMNs Gi-coupled G-protein coupled receptors (GPCR)
with agonists, such as the N-formyl-L-methionyl-L-leucyl-L-
phenylalanine peptide (fMLP) released by the bacterial cell wall
at the infection site, leads to activation of the intra-cytoplasmic
subunits of the nicotinamine adenine dinucleotide phosphate
(NADPH) oxidase [7]. This membrane enzyme catalyzes the
oxidation reaction of both NADPH and nicotinamine adenine
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dinucleotide (NADH) coenzymes by oxygen to produce reactive
oxygen species responsible for bactericidal activity [8]. This non-
mitochondrial generation of ROS is a massive and fast process
known as a respiratory or oxidative burst. The toll-like receptors
(TLRs) also play a critical role in the recognition of bacteria. They
activate the nuclear transcription factor nuclear factor-kappa B
and induce the production of pro-inflammatory cytokines, such as
tumor necrosis factor-alpha (TNF-a) [9–11]. This massive increase
in protein synthesis dramatically modifies the oxydo-reduction
metabolism in the cells and, consequently, NADH concentration
[12–15]. Thus, the host’s leukocyte activation could be tracked by
measuring the variations in the two reduced pyridine nucleotides,
NADH and NADPH, that exhibit a similar visible fluorescence
referred to as NAD(P)H.
Several animal studies have used the NAD(P)H autofluores-
cence signal to distinguish and sort PMNs from other types of cells
in either bone marrow [16] or broncho-alveolar lavage (BAL)
[17,18] samples. Elsewhere, in vitro studies have been performed
on living cells [19–21] to demonstrate any impact of triggering
human PMNs respiratory burst on their NAD(P)H autofluores-
cence intensity. To the best of our knowledge, such approach has
never be extended to either TLRs signalization pathway activation
of PMNs or to in vivo BI which could be a promising, non-invasive,
rapid and inexpensive tool for early BI diagnosis.
Firstly, an ex vivo infection model was developed in human-fixed
PMNs specifically stimulated with fMLP and TLR agonists,
demonstrating the workability of the NAD(P)H fluorescence signal
of the cells. We observed significant changes in the autofluores-
cence intensity of the stimulated PMNs compared with resting
cells. Secondly, the study was carried out using a mouse model,
enabling us to assess pneumonia with certainty and to obtain the
ascertained negative controls. For this in vivo model, changes in
autofluorescence intensity signal of fixed PMNs obtained from
BAL were observed between the infected and non-infected mice.
Finally, the method was extended to BAL obtained from ICU
patients, revealing PMNs autofluorescence alterations for patients
with ventilator-associated pneumonia (VAP).
Materials and Methods
Ethics statement
This work is part of a global study on ICU-induced
inflammatory dysfunction. In this setting, all the studies involving
a biological sampling at our institution were recorded and were
declared to the French Ministry of Health in 2008 (authorization
number: AC 2008–433) after approval by the institutional review
board of Angers (19-12-08). ICU patients were ventilated and
sedated when samples were collected. For the global study written
informed consent was mandated from a next-of-kin. Considering
the present study, BAL samples for PMNs analysis were collected
from residual BAL after completion of routine follow-up. The
institutional review board of Nantes (NuDC-2011-1399) waived
written inform consent and authorized verbal informed consent
from relatives and retrospective information was provided to
patients. Healthy donors provided written informed consent before
blood sampling. The total blood volume collected from each
volunteer was 25 mL.
Concerning the animal in vivo model, the committee of animal
ethics of the University of Nantes approved all of the animal
experiments in this study.
Human cell culture and stimulation
PMNs were isolated from whole blood of healthy donors by
centrifugation over a density gradient of Lympholyte-Poly
(Cedarlane Tebu-bio, Le Perrey-en-Yvelines, France). Two
distinct cell rings were obtained, and the PMNs were taken from
the lower ring. PMNs were then centrifuged and resuspended in
0.45% NaCl, washed twice, and incubated at 37uC in 4-well Lab-
TekTM slides (Nunc, Roskilde, Denmark) at a concentration of
86105 cell/ml in RPMI (Invitrogen, Paisley, United Kingdom)
supplemented with 4% human AB serum, penicillin G (100 U/ml)
and streptomycin (100 mg/ml) (Valbiotech, Paris, France). Lab-
TekTM slides were preferentially used regarding the need to
regularly monitor PMN cell cultures with an inverted microscope
as well as the optimal adherence, viability and seeding quality of
the neutrophils previously noted on glass coverslip chambers.
After 24 hours, to mimic BI, PMNs were stimulated 90 minutes
with 50 mg/mL of purified lipopolysaccharide (LPS) from Esche-
richia coli (Sigma, St. Louis, MO) to activate the TLR4 pathway;
with 10 mg/mL of the synthesized peptidoglycan Pam3Csk4
(InvivoGen, San Diego, USA) to activate the TLR2 pathway; or
with 1026 mol/L of the peptide fMLP (Sigma-Aldrich, St Quentin
Fallavier, France) to activate a TLR independent signaling
pathway GPCR. For the control samples, PMNs were not
stimulated.
Fixed human cellular sample
To make our ex vivo model available as a tool for routine
diagnosis, we optimized the study for fixed cells. Thus at the end of
all activation conditions (t = 90 minutes, which corresponds to the
activation time of cytokine production), supernatants were
discarded and 56105 PMNs were gently resuspended by smooth
pipetting, cytospined on glass slides, fixed for 10 minutes with 4%
paraformaldehyde (PFA), and mounted with ProLong Gold
antifade reagent (Invitrogen, Paisley, United Kingdom). Under
these conditions, PMNs remained stable and readable for
autofluorescence over several months for slides kept in the dark
at 4uC.
Human cytokine assay
Neutrophils from healthy donors were cultured for 90 minutes
in 24-well plates (16106 cells/well) in medium (RPMI + fetal
bovine serum 10%) alone (control, C), or with LPS (E. coli
O111:B4, 1 mg/ml; Sigma), Pam3Csk4 (1 mg/ml; Sigma), or
fMLP (1 nM; Sigma) in a 5% CO2 incubator at 37 uC.
Supernatants were collected by centrifugation at 12000 6 g for
2 minutes and stored at 280uC before cytokine determination by
enzyme linked immuno-sorbent assay kits according to manufac-
turer instructions (R&D Systems, Abingdon, United Kingdom).
Alveolar lavage from pneumonia and LPS-induced acute
lung injury (ALI) model in mice
Male BALB/cJ (20–24 g) mice were purchased from Janvier
Laboratories, Laval, France. Mice were maintained on a 12-hours
light/dark cycle with free access to food and water. Methicilline-
susceptible Staphylococcus Aureus strains (ATCC 29213) and Pseudo-
monas aeruginosa (ATCC 51675) were grown for 18 hours in tryptic
soy broth at 37 uC. Immediately before use, cultures were washed
twice, with centrifugation at 10006g for 10 minutes at 37 uC, and
then diluted in sterile isotonic saline to be calibrated by
nephelometry (161010 and 16109 Colony Forming Unit (CFU)/
ml for Staphylococcus aureus and Pseudomonas aeruginosa, respectively).
Bacterial concentration (CFU/ml) was controlled by quantitative
culture. Pneumonia and LPS-induced ALI model were induced
according to previously published methods [22,23]. Briefly, mice
were anesthetized with isoflurane and placed in dorsal recumben-
cy. Transtracheal insertion of a 24-gauge feeding needle was used
Neutrophils Autofluorescence for Sepsis Diagnosis
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to inject 70 ml either the bacterial preparation or LPS (E.Coli
O111:B4, 10 mg/Kg; Sigma). The rate of intratracheal inocula-
tion reaches 100% with this procedure. The mice were euthanized
24 hours after tracheal instillation. Lungs were flushed with 1 ml
of saline to obtain BAL fluids and 500 ml were cytospined on glass
slides (6 minutes at medium speed), fixed 10 minutes with 4%
PFA, and mounted with ProLong Gold antifade reagent (Invitro-
gen, Paisley, United Kingdom) for further autofluorescence
intensity signal analysis.
Total cell numbers in each BAL were counted using a Coulter
counter (Beckmann Coulter, Fullerton, CA, USA) and differential
cell counts were performed on cytospin preparations stained with
Giemsa. The percentage of PMNs in BALs, defined as Gr-
1posCD11bpos cells, was determined by flow cytometry analysis
(BD Bioscience, LSR-II). Monoclonal antibodies used for flow
cytometry were obtained from BD Biosciences (Le Pont de Claix,
France): anti-CD11b (M1/70), and from eBiosciences (San Diego,
CA, USA): anti-Gr-1 (RB6-8C5). The percentage of PMNs in
BAL was also performed by using Ly6G [24]. Data were analyzed
using FlowJo software (Treestar, USA).
Alveolar lavage from patients with ventilated-associated
pneumonia (VAP)
Pneumonia was considered when at least 2 signs (body
temperature .38uC; purulent pulmonary secretions; leukocytosis
.12000/mL or leukopenia ,4000/mL) were associated with the
appearance of a new infiltrate or changes in an existing infiltrate
on chest X-ray. When VAP was suspected, the ICU physician
performed a BAL in the affected region of the lung, identified from
a chest radiograph, to confirm the diagnosis. The presence of
squamous epithelial cells, bronchial cells and bacteria were noted
following cytocentrifugation (1500 rpm, 15 mn) and a Gram stain.
Fifty mL of BAL (without dilution) were plated on Columbia 5%
sheep-blood agar, and on chocolate PolyViteX agar, using a spiral
system. All plates were incubated at 37uC under 5% CO2, for
24 h or 48 h. A quantitative BAL was defined as positive if there
were more than 104 CFU/mL [25,26]. The final diagnosis of VAP
was based on a Clinical Pulmonary Infection Score $6 [27]. BAL
fluids (500 ml) were cytospined on glass slides (6 minutes at
medium speed), fixed for 10 minutes with 4% PFA, and mounted
with ProLong Gold antifade reagent Invitrogen, Paisley, United
Kingdom) for further autofluorescence intensity signal analysis.
Fluorescence imaging
Fluorescence images were first performed using a TCS SP5
AOBS (Leica Microsystems; implemented at the Centre de
Photonique Biome´dicale of Orsay). Cells were observed using a
63x, 1.4 numerical aperture plan Apochromat oil immersion
objective. An Argon ultraviolet laser with a maximum wavelength
of 364 nm (1.3 mW mesured at the back focal plan of the
objective) was used as the excitation source for the cell endogenous
NAD(P)H. Fluorescence was collected in the 400–550 nm range.
The flavin fluorescence, which was tested with an Argon laser with
maximum wavelength of 488 nm, appeared to be insignificant in
these immune cells (data not shown). The resolution of the
confocal images was 5126512 pixels (corresponding to an area of
,2506250 mm2), recorded on 12 bits with a zoom value of one.
Each image corresponds to an average of four scans. The
quantification of the fluorescence intensity was carried out with
LASAF software (Leica Microsystems, Wetzlar, Germany) using
Region of Interest (ROI) over isolated cells present in the field of
each image (approximately 10 ROI per image). Each ROI was
carefully outlined by avoiding any area presenting multi-layer
superoposed cells. Data were collected in three to five independent
experiments for each condition. For the mouse and human BAL
study, fluorescence intensity analyses were carried out by two
different trained operators blinded to mouse or patient status.
Further fluorescence images were obtained using a conventional
right epifluorescence microscope (Olympus BX 51, Tokyo, Japan)
equipped with a continuous mercury-arc lamp (X-cite 120Q,
EXFO) for excitation and a monochrome cooled CCD camera
(CCD XM10 camera, Olympus) for fluorescence emission
detection through a 40x objective. The resolution of the images
was 137661038 pixels (corresponding to an area of
,2206170 mm2), recorded on 14 bits. Fluorescence images were
analyzed similarly to confocal images but using ICY software
(Institut Pasteur, Paris, France).
Statistical analysis
Results are expressed as mean 6 Standard Deviation (SD) if the
data were normally distributed and median interquartile range if
not. Normality of the distribution was verified by the Shapiro-Wilk
test and scattered dot plots.An ANOVA with a Student t-test using
Bonferroni’s correction for post-hoc analysis was performed for
multiple comparisons if the data were normally distributed. If not,
a Kruskal Wallis test with Mann-Whitney test using Bonferroni’s
corrections for post-hoc analysis was used. A receiver-operating
curve was built by plotting the sensitivity (true positive rate) as a
function of the false positive rate (100-specificity) at different
fluorescence intensities. The threshold associated with the best
relationship between sensitivity and specificity was determined
according to the Youden Index. A value of p,0.05 was considered
statistically significant. All statistical analysis was performed using
SPSS 13.0 software (Chicago, IL, USA).
Results
Autofluorescence intensity from human ex vivo
stimulated PMNs is different from resting PMNs
PMNs, which are critically involved in the host defense against
pathogens, were stimulated with the TLR4 and TLR2 agonists
(LPS and Pam3Csk4, respectively) and a GPCR agonist (fMLP).
We first verified that these agonists effectively stimulated PMNs
by measuring TNF-a production after stimulation and compared
it with resting PMNs (Figure 1). As expected, TLR agonists (LPS
and Pam3Csk4), but not fMLP, induced a TNF-a production in
PMNs when compared with untreated PMNs.
Eight healthy volunteers were sampled to study 1205 fixed
PMNs. Typical overall fluorescence intensity images of the three
stimulated and control PMNs groups are illustrated Figure 2 A.
The autofluorescence mean values of LPS (93.6616.2 AU) and
fMLP (61.1618.6 AU) stimulated PMNs were significantly lower
than the normalized baseline autofluorescence value of unstimu-
lated PMNs (100 AU; Figure 2 B). For the Pam3Csk4-stimulated
PMNs group, the fluorescence variation was not significant. We
noted that the decrease of the mean fluorescence intensity was
much greater for cells stimulated by fMLP (,40% fluorescence
decrease compared with the control group).
Autofluorescence intensity in cytospined BAL from
pneumonia mouse model samples is different from
control samples
Validation of the pneumonia mice model was previously
described by Roquilly et al. [22,28]. Flow cytometry analyses
were performed on cells obtained from BAL (Pseudomonas aeruginosa
and Staphylococcus aureus pneumonia models; Figure 3). We found
the presence of 67.7% (51.3–70.2%) and 70.2% (68.8%–84.3%) of
Neutrophils Autofluorescence for Sepsis Diagnosis
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neutrophils respectively compared with 5.0% (1.3%–8.6%) of
neutrophils in the control group (Figure 4). Using Ly6G, the best
marker to discriminate neutrophils in a population of myeloid cells
[24], we confirmed that neutrophils were the major cell population
in BAL from infected mice with Pseudomonas aeruginosa and
Staphylococcus aureus: 64.2% (53.7–76.9%) and 81.3% (68.1%–
84.9%) of neutrophils respectively compared with 7.0% (1.4%–
10.1%) of neutrophils in the control group (Figure S1). These data
indicated that the majority of the leukocytes studied in BAL
cytospined samples were neutrophils, which correlated with a
classical bacterial pneumonia observed in the patients.
Typical histological lung damage and autofluorescence images
of BAL cytospined cells from Pseudomonas aeruginosa or Staphylococcus
aureus pneumonia mouse models are shown in Figure 5. Histolog-
ical analysis of lung tissue showed thin-walled air spaces with a
single pneumocyte layer observed in control mice (Figure 5 A)
compared with an alveolar layer thickening and immune cell
infiltration after Staphylococcus aureus (Figure 5 B) or Pseudomonas
aeruginosa (Figure 5 C) infection. Twenty-nine mice were sampled
to study the autofluorescence of 599 cells. The mean autofluores-
cence value for the cytospined cells from BAL after Pseudomonas
aeruginosa pneumonia (Figure 5 E) was significantly lower than the
value after Staphylococcus aureus (Figure 5 F) pneumonia
(44.8616.3 AU and 66.3630.6 AU respectively). Both were
significantly lower (from 40 to 60%) than the mean autofluores-
cence value of the cytospined cells from BAL in control mice
(107.5633.9 AU; Figure 5 G).
The receiver operating curve for fluorescence intensity for cells
from non-infected and infected BAL mice showed an area under
curve of 0.8960.01 (p,1024; Figure 5 H). As best cut-off for the
diagnosis of pneumonia, the Youden index identified an autofluo-
rescence intensity of 75.5 AU (Sensitivity 84%, Specificity 81%).
The autofluorescence intensity in cytospined BAL from
pneumonia mouse model samples is different from LPS-
induced ALI samples
The murine intratracheal LPS-induced ALI model has been
previously validated [23]. This model generates a maximal PMNs
accumulation in airways and histological injury 24 hours after LPS
instillation. In this separate set of experiments (Figure 6), 15 mice
were sampled to study the autofluorescence of 1580 cells. The
mean autofluorescence intensity of the cytospined cells from BAL
samples was significantly lower in the Pseudomonas aeruginosa group
than either the control or the LPS-induced ALI groups (909 [600–
1398] AU versus 1190 [755.5–2098] AU and 1180 [801–1800]
AU, respectively; Figure 6 C). No difference was observed between
the control and the LPS-induced ALI groups (Figure 6 C).
These assays were first performed with a confocal microscope
and duplicated using a standard epifluorescence microscope. Even
with this classical-resolution microscope a very good fluorescence
contrast was observed between the different cells (figure 6 B) and
Figure 1. Ex vivo production of tumor necrosis factor alpha
(TNF-a) by human neutrophils. The release of TNF-a from non-
stimulated (control, C) neutrophils, or LPS- (LPS), Pam3Csk4- (Pam), and
fMLP- (fMLP) stimulated neutrophils after 90 minutes were measured
with enzyme-linked immunosorbent assay. Boxes represent median
(interquartile range). Kruskal-Wallis test with post-hoc analysis by Mann-
Whitney test using Bonferroni’s corrections were used to compare
responses with and without PRRs ligands. *p,0.05. These data are
representative of two different experiments.
doi:10.1371/journal.pone.0092564.g001
Figure 2. Representative fluorescence intensity variations between ex vivo stimulated and non-stimulated cytospined PMNs. A)
Representative images of autofluorescence intensities of non-stimulated PMNs (control C), and LPS-, Pam3Csk4- (Pam), and fMLP-stimulated cells
(Scale bar, 50 mm). B) The results are represented as boxplots of normalized fluorescence intensity to graphically depict the groups of numerical data
for each stimulation condition (n = 1205 studied PMNs from eight healthy volunteers). Boxes represent median (interquartile range). ANOVA with
post-hoc analysis by t-test using Bonferroni’s correction was used to compare autofluorescence levels between each group. *: p,0.001 stimulation
groups versus control group, *: p,0.001 fMLP group versus LPS and Pam, J: p,1024 fMLP group versus Pam3Csk4 group, J: p,1024 fMLP group
versus Pam3Csk4 and LPS, $: p = 0.004 Pam3Csk4 group versus LPS group.
doi:10.1371/journal.pone.0092564.g002
Neutrophils Autofluorescence for Sepsis Diagnosis
PLOS ONE | www.plosone.org 4 March 2014 | Volume 9 | Issue 3 | e92564
statistical analysis confirmed that the mean fluorescence value of
the cytospined cells from BAL with Pseudomonas aeruginosa
pneumonia was ,20–30% lower than for BAL from control or
LPS-induced ALI mice (Figure 6 D).
Autofluorescence intensity in cytospined BAL from
human VAP
We analyzed the BAL from nine ventilated ICU patients in
order to validate our results in a clinical setting. The general
characteristics of patients are presented in Table 1. The median
clinical pulmonary infection score (Table 2) was 7 (6–9) on the day
of BAL sampling. Typical autofluorescence images of cytospined
cells from patients without VAP and with VAP are shown in
Figure 7 A. Next, 720 ROI were quantified, revealing a mean
autofluorescence intensity value of the cytospined cells from VAP
patients that was 2.7-fold lower than from patients without VAP
(42.4620.3 AU and 115.2639.5 AU, respectively; Fig 7 B). The
region ROI quantification was blinded to the VAP diagnosis.
Discussion
After a BI, PMNs are the first and largest population of immune
cells present in the blood and also in the lungs in the case of
pneumonia [29]. In the current study, we took advantage of
NAD(P)H autofluorescence modifications observed in PMNs to
validate a new tool for diagnosing BIs. Furthermore, we
demonstrated that this PMNs autofluorescence signal alteration
is specific to pneumonia, making it possible to distinguish bacteria-
induced inflammation from a non-infectious lung injury.
Our ex vivo model using stimulated fixed and mounted human
PMNs showed that the autofluorescence signal displayed signifi-
cant decreases when PMNs were challenged with fMLP or TLR
agonists compared with resting cells, revealing cell metabolism
modifications after stimulation. PMNs are known to have a very
high level of oxidative burst potency, mainly relayed by the
NAD(P)H oxidase function [7,8]. Thus, the main effect of the
stimulation of PMNs by pathogens, via fMLP instead of TLRs
agonists, can be reasonably explained by significant depletion in
cytosolic NAD(P)H concentration which correlates with the
observed decrease in autofluorescence intensity. In agreement
with our results, it has already been demonstrated that GPCR
engagement results in little or no cytokine release in neutrophils.
Interestingly, previous in vitro studies carried out on human PMNs
exposed to either phorbol diester [19] or fMLP [21], as respiratory
burst triggers, reported similar results. Using either a flow
cytometry [19] or epi-fluorescence microscopy method [21], both
studies demonstrated a drop in the NAD(P)H autofluorescence
intensity of such stimulated-PMNs. However, another study found
a 2-fold increase in NAD(P)H autofluorescence intensity of human
PMNs activated in vitro with fMLP, compared with resting
neutrophils [20]. Several remarkable differences and limitations
in the experimental settings could account for these discrepancies.
In particular, PMNs stimulation could lead to cell clumping [30],
and experiments by flow cytometry or spectrofluorometry using
high cell concentrations could therefore result in a disruption in
fluorescence signal processing. Autofluorescence intensity quanti-
fication based on cell imaging allowed us to precisely acquire the
signal from individual cells, ruling out cell superposition. In an
attempt to validate the results of our ex vivo model, we assessed the
cellular autofluorescence alterations in a validated mouse model of
pneumonia [22,28]. This model closely resembles what happens in
the clinical scenario, and permitted us to eliminate any false
positive or negative values. In this context, Staphylococcus aureus
(Gram-positive bacteria) and Pseudomonas aeruginosa bacteria (Gram-
Figure 3. Neutrophils relative proportion determination by flow cytometry study. Example of representative gating obtained by flow
cytometry of BAL collected from non-infected mice (PBS treatment: control, C) or pneumonia mouse model 24 hours after tracheal instillation of
Pseudomonas aeruginosa, PA; or Staphylococcus aureus, SA. For this experiment, neutrophils were considered as Gr-1pos CD11bpos cells.
doi:10.1371/journal.pone.0092564.g003
Figure 4. Evaluation of the neutrophil population in control
and Pseudomonas aeruginosa-or Staphylococcus aureus-induced
pneumonia mice. Proportions of neutrophils (Gr-1pos CD11bpos) were
assessed in murine BALs 24 hours after intra-tracheal instillation of
saline solution (C), Pseudomonas aeruginosa (PA) or Staphylococcus
aureus (SA). Boxes represent median (interquartile ranges) from three
independent experiments (n$5 mice per group). A Kruskal-Wallis test
with Mann-Whitney test using Bonferroni’s corrections for post-hoc
analysis was used. *: p,0.001 compared with the sham group.
doi:10.1371/journal.pone.0092564.g004
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negative bacteria) were chosen because they are critically involved
in many human community and nosocomial infections. We first
clarified the cell population nature in BAL samples. Although
some consensus exists on the very low or absence of autofluores-
cence properties of lymphocytes [16,17], conflicting data remain
about either the relative monocyte [16–18,20] or eosinophil
[17,31] autofluorescence intensity compared with the neutrophil
autofluorescence signal. Considering the present results, we used
LY6G in animal experiments, the most specific antibody to isolate
neutrophils among myloid cells [24]. Also, in human BAL,
neutrophils are by far the largest population of cells, and their
morphology is characteristic. The mean autofluorescence intensity
variation caused mainly by PMNs from infected animals, as
revealed by flow cytometry analysis, was significant enough to
distinguish a cytospined BAL from a control mouse from a
cytospined BAL from a mouse with pneumonia. These data
confirmed the results obtained using the ex vivo model, which
showed a decrease in fluorescence in the host cells challenged by
fMLP or LPS compared with resting cells.
We further investigated wether or not the PMNs autofluores-
cence level could distinguish an infection-triggered from a non-
septic lung inflammation. The LPS-induced ALI model was
chosen because this procedure is reproducible, well validated and
strongly featured in the literature [23]. LPS is specific to Gram-
negative bacteria, and was therefore an accurate positive control
for our Pseudomonas aeruginosa pneumonia model as infectious
model. The results suggest that our technique remains capable of
discriminating the autofluorescence intensity level of pneumonia
from a non-infectious ALI. Furthermore, no difference was found
in PMNs autofluorescence signal of BAL samples between the ALI
and control groups, which means that in the context of pneumonia
diagnosis, non-infectious ALI could not be detected as a false
positive.
After validation of these models, we tested our new tool for
diagnosing infections in a clinical setting. For this purpose, PMNs
from BAL harvested in mechanically ventilated patients suspected
of having VAP were used. VAP is a leading cause of death in ICU
patients. Its diagnosis is particularly challenging for the attending
physician since current criteria are neither sensitive nor specific
Figure 5. Fluorescence intensity and histology images of BAL in control and Pseudomonas aeruginosa- or Staphylococcus aureus–
induced pneumonia mice. Control condition histology (A) and fluorescence intensity imaging (D); Staphylococcus aureus-induced pneumonia
histology (B) and fluorescence intensity imaging (E); Pseudomonas aeruginosa-induced pneumonia histology (C) and fluorescence intensity imaging
(F). Scale bar, 50 mm. (G) Boxplot representation of fluorescence intensity in arbitrary units (I (AU)) of BAL for non infected mice (control, C) and
Pseudomonas aeruginosa (PA) or Staphylococcus aureus (SA) induced pneumonia in mice. Boxes represent median (interquartile range). Data are
representative of two independent experiments (Control group, n = 8; Pseudomonas aeruginosa group, n = 9; Staphylococcus aureus group, n = 12).
ANOVA with post-hoc analysis by t-test using Bonferroni’s correction was used to compare autofluorescence levels between each group. *: p,1024
Pseudomonas aeruginosa and Staphylococcus aureus groups versus control group. &: p,1024 Pseudomonas aeruginosa group versus Staphylococcus
aureus group. BAL and background noise intensities are different in each condition (p,1024). (H) Receiver operating curve of fluorescence intensity
of cells between controls and induced-infectious pneumonia in mice. AUC 6 Standard Error: area under curve. *p,1024.
doi:10.1371/journal.pone.0092564.g005
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[32]. Thus, there is an urgent need to provide new diagnostic tools
to complement common clinical and bacteriological indicators.
Our results demonstrate that a major difference in the mean
autofluorescence intensity of human cells leads to the differenti-
ation of cytospined BALs collected from patients with and without
VAP. Thus, as far as VAP is concerned, we could imagine that the
mean autofluorescence intensity of a cytospined BAL could help to
confirm or to rule out the final diagnosis of VAP in ICU patients.
To our knowledge, no studies have previously reported a potential
use of PMNs NAD(P)H autofluorescence signal in human sepsis
setting. Interestingly, in a flow cytometry study in blood PMNs,
Kim et al. reported that flavin adenine dinucleotide fluorescence
level chemically enhanced by Zn2+ dipicolylamine, could distin-
guish cells with from those without toxic granulations with a
sensitivity of .90% and a specificity of .80% [33]. However,
since toxic granules can be found in multiple neutrophil
abnormalities and diseases distinct from infection, detecting them
for improving sepsis diagnosis remains questionable.
A tool for the early diagnosis of BIs would enable the attending
physician to start antibiotic therapy only in cases of proven
infection, and to not start antibiotherapy if infection is unlikely. In
this context, several biomarkers have been validated, such as PCT,
probably the most widely used [34]. It was first proposed as an
early marker of infection, but it was then determined that PCT
was more useful to determine when to stop antibiotic therapy
(antibiotic exposure can be reduced by three to seven days [6])
than for diagnosing infections. Nevertheless, the results of
biomarker-guided therapies are not immediately available (results
are available after hours or days) and the average cost for a single
PCT analysis is high [6]. Several other biomarkers have been
investigated in the field of early diagnosis of sepsis. Sensitivities and
specificities of over 90% have been reported for 5 of them:
interleukin IL-12 [35], interferon-induced protein 10 [36], group
Figure 6. Representative fluorescence intensity images and values in control, LPS-induced acute lung injury and Pseudomonas
aeruginosa-induced pneumonia in mice. Fluorescence intensity imaging by confocal microscopy (A) and standard epifluorescence microscopy
(B) of cytospined BAL samples from Control, LPS-induced acute lung injury (LPS) and Pseudomonas aeruginosa-induced pneumonia (PA) in mice. Scale
bar, 50 mm. Boxplot representation of fluorescence intensity in arbitrary units (I (AU)) of BAL samples in the 3 different conditions (Control (C), LPS,
PA), from confocal images (C) and classical epifluorescence images (D). Boxes represent median (interquartile range). Control group, n = 6, LPS group,
n = 7, Pseudomonas aeruginosa group, n = 2. Group comparisons were analyzed by Kruskall-Wallis test with a Mann-Whitney test using Bonferroni’s
corrections for post-hoc analysis. (C) *: p,1024 Pseudomonas aeruginosa group versus control group. &: p,1024 Pseudomonas aeruginosa group
versus LPS group. (D) *: p,0.001 Pseudomonas aeruginosa group versus control group. &: p,1024 Pseudomonas aeruginosa group versus LPS group.
doi:10.1371/journal.pone.0092564.g006
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II phospholipase A2 [37], CD64 [38] and neutrophil CD11b [39].
However, aside from pediatric or bacteriemic patients, IL-12 [35],
interferon-induced protein 10 [36], CD11b [39] and group II
phospholipase A2 [37] have never been evaluated for diagnosis of
VAP in adult patients. Interestingly, in a clinical trial involving 135
patients with confirmed viral or BIs, Nuutila et al.[38] reported a
high sensitivity (94%) and specificity (98%) for CD64 in
distinguishing febrile infections from healthy volunteers. Finally,
even if some cytokines, such as TNF and IL-10 [40], are produced
rapidly after the onset of sepsis, most of these proteic biomarkers
need few hours to be generated, secreted and then, detected. By
contrast, pathogen-induced metabolic changes in PMNs, such as
respiratory burst, are fast, and the resulting changes in autofluo-
rescence intensity are detectable within an hour. PCR technology
is another biomarker approach which is available at bedside and
detects pathogen DNA. It is an easy method with commercial kits,
but like PCT, it is expensive and diagnosis is not immediately
available. Also, contamination of samples can give ‘‘false- positive
results’’ in 0.6 to 6% of the cases [41].
Figure 7. Representative fluorescence intensity images and values in patients with and without VAP. Nine patients were successively
screened. Pneumonia was considered when at least two signs (body temperature .38uC, purulent pulmonary secretions, and leukocytosis .12000/
mL or leukopenia ,4000/mL) were associated with the appearance of a new infiltrate or changes in an existing infiltrate on chest x-ray. BAL was
performed to confirm the diagnosis. The final diagnosis of VAP was based on a clinical pulmonary infection score $ 6. A) Representative images of
autofluorescence intensities of cytospined BAL from patients without VAP (upper panels) and with VAP (lower panels). Scale bar, 50 mm. B) The
results are represented as boxplots of fluorescence intensity to graphically depict the groups of numerical data for each group of patients (n = 169
studied ROI from 2 patients without VAP, n = 551 studied ROI from 7 patients with VAP). Boxes represent median (interquartile range). Student’s t-test
was used to compare autofluorescence intensity between both groups. *: p,0.0001 VAP patients (pneumonia) versus non-VAP patients (no
pneumonia).
doi:10.1371/journal.pone.0092564.g007
Table 1. Characteristics of ICU patients (with and without VAP) in which BAL was performed to evaluate neutrophil
autofluorescence.
N=9
Age, years – median (interquartile range) 42 (37–64)
Male – N (%) 6 (67)
Simplified acute physiology score II – median (interquartile range) 50 (40–57)
Initial condition – N (%)
Trauma 6 (67)
Sepsis 2 (22)
Respiratory failure 1 (11)
Clinical Pulmonary Infection Score – median (interquartile range) 7 (6–9)
Pathogens – N (% of VAP)
Staphylococcus aureus 2 (22)
Streptococcus pneumoniae 3 (33)
Haemophilus influenzae 1 (11)
Enterobacter spp 2 (22)
Oropharyngeal flora 1 (11)
No pathogens in culture 1 (11)
Duration of mechanical ventilation, days – median (interquartile range) 13 (7–20)
ICU length of stay, days – median (interquartile range) 17 (8–37)
Death in ICU, N (%) 2 (22)
doi:10.1371/journal.pone.0092564.t001
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Our strategy based on autofluorescence variations in PMNs can
help to diagnose or excluding BIs, in conjunction with other
clinical and bacteriological methods. The method is especially
attractive since it provides results in one hour. Furthermore, we
standardized the cell fixation technique in a very simple, fast, and
reproducible way and confirmed that is possible to use a classical
epifluorescence microscope which can easily be applied in a
regular hospital bacteriology laboratory.
One of the limitations of the study is that our new optical
diagnosis tool, like most biomarkers for sepsis, could provide false-
positive and false-negative results. Our clinical data should be
interpreted with caution. The small number of cases does not
make it possible to report accurate sensitivity or specificity. Further
large scale clinical studies are warranted before drawing a
definitive conclusion. Second, the criteria used for the diagnosis
of VAP could impact the results of the present study. Clinical
pulmonary infection score is not superior to conventional clinical
criteria [42]. However it is useful for the decision to initiate
probabilistic antibiotherapy [43] and for using short course
antibiotic therapy in patients with a low likelihood of pneumonia
[44]. Another limitation is that the present study is limited to a
mouse model and human pneumonia, i.e. an autofluorescence
signal provided mainly from PMNs. The next step for developing
this new tool will be to investigate other in vivo infected clinical
samples, such as those that are virally infected.
In summary, this study demonstrates that the autofluorescence
of PMNs is helpful and easy to use, even in a routine
microbiological laboratory setting. The immediate analysis of
mean autofluorescence intensity of PMNs cytospined samples can
detect a host-pathogen interaction as a surrogate marker of
infection. In the future, this new technique could be used to detect
changes in leukocyte metabolism, which could lead to the
optimization of rapid infection diagnosis without the need to
directly determine the pathogen or wait for bacterial culture
results. Moreover, analysis of PMN autofluorescence could
enhance infection diagnosis in the cases of failure of typical
bacteriological laboratory techniques.
Supporting Information
Figure S1 Evaluation of the neutrophil population in control
and Pseudomonas aeruginosa-or Staphylococcus aureus-induced pneumo-
nia mice. Proportions of neutrophils (Ly6Gpos CD11bpos) were
assessed in murine BAL 24 hours after intra-tracheal instillation of
saline solution (C), Pseudomonas aeruginosa (PA) or Staphylococcus aureus
(SA). Boxes represent median (interquartile ranges) from 2
independent experiments (n$5 mice per group). A Kruskal-Wallis
test with Mann-Whitney test using Bonferroni’s corrections for
post-hoc analysis was used. *: p,0.001 compared with sham
group.
(TIF)
Table 2. Clinical pulmonary infection score.
Temperature (6C)
$ to 36.5uC and, or equal to 38.4uC 0 point
$ to 38.5uC and, or equal to 38.9uC 1 point
$ to 39uC and, or equal to 36uC 2 points
Blood leukocytes, (/mm3)
$4,000 and, # to 11,000 0 point
,4,000 or .11,000 1 point
and if band forms $ to 50% 1 point
Tracheal secretions
Absence of tracheal secretions 0 point
Presence of nonpurulent tracheal secretions 1 point
Presence of purulent tracheal secretions 2 points
Oxygenation
Ratio PaO2/FIO2 .240 or acute respiratory distress syndrome 0 point
Ratio PaO2/FIO2 # equal to 240 and no acute respiratory distress syndrome 2 points
Pulmonary radiography
No infiltrate 0 point
Diffuse (or patchy) infiltrate 1 point
Localized infiltrate 2 points
Progression of pulmonary infiltrate
No radiographic progression 0 point
Radiographic progression 2 points
Culture of tracheal aspirate
Pathogenic bacteria cultured in rare or light quantity or no growth 0 points
Pathogenic bacteria cultured in moderate or heavy quantity 1 point
Same pathogenic bacteria seen on Gram stain, add 1 point 1 point
doi:10.1371/journal.pone.0092564.t002
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